Conference Proceedings
Correlation of Bridging Therapy (BT) and Lymphodepleting Chemotherapy (LDC) with clinical outcomes in patients (pts) with relapsed/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL) treated with tisagenlecleucel
C Andreadis, CS Tam, P Borchmann, U Jaeger, JP McGuirk, H Holte, EK Waller, S Jaglowski, MR Bishop, SR Foley, JR Westin, I Fleury, PJ Ho, S Mielke, T Teshima, GA Salles, SJ Schuster, V Bachanova, RT Maziarz, K Besien Show all
ONCOLOGY RESEARCH AND TREATMENT | KARGER | Published : 2020